Skip to main content
. 2012 Feb 3;7(2):e30921. doi: 10.1371/journal.pone.0030921

Figure 3. In vitro induced mutation patterns of TP53.

Figure 3

(A) In vitro Acetaldehyde-exposed human fibroblasts AG1521 (FASAY) (n = 35 mutations, data from [15]), (B) In vitro AFB1-exposed human fibroblasts AG1521 (FASAY) (n = 37 mutations, data from [16]), (C) In vitro B[a]P-exposed human fibroblasts AG1521 (FASAY) (n = 37 mutations).